Halipa, Jaharia .

HRN: 18-69-41  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/14/2025
COTRIMOXAZOLE 960MG (TAB)
12/14/2025
12/20/2025
PO
960mg
Q12
T/C Catheter Associated UTI
Checking Final Appropriateness 

Indication:  Empiric    Type of Infection:  Urinary Tract    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Intervention



Type of Intervention done:

                    

           


Acceptance: